[初级胆道炎 - - 诊断,风险分层和新治疗方案的最新情况]
Toni Herta1,2, Thomas Berg3
1Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum und Campus Charité Mitte, Augustenburger Platz 1, 13353, Berlin, Deutschland. toni.herta@charite.de.
Innere Medizin (Heidelberg, Germany)
|September 4, 2025
概括
新的过氧酶增殖器激活受体 (PPAR) 激活剂为初级胆道胆炎 (PBC) 患者提供了改善的治疗选择,这些患者对乌尔索二氧化醇酸无反应. 这些药物有望控制胆固醇和,提高患者的护理.
科学领域:
- 肝病学
- 免疫学
- 药理学
背景情况:
- 原发性胆道炎 (PBC) 是一种慢性自身免疫性肝病.
- 乌尔索多西可酸 (UDCA) 是一线治疗,但40%的患者反应不充分.
- 在PBC治疗中,治疗症状,特别是,至关重要.
研究的目的:
- 提供关于PBC诊断,风险分层和治疗的全面更新.
- 专注于新型过氧酶增殖器激活受体 (PPAR) 激活剂在二线治疗中的作用.
- 讨论PBC患者治疗的实用策略.
主要方法:
- 对PBC诊断和治疗的当前文献的审查.
- 对新型PPAR激动剂 (elafibranor,seladelpar) 的临床试验数据的分析.
- 作为PPAR激动剂的非标签使用的讨论.
主要成果:
- 新型PPAR激动剂 (elafibranor,seladelpar) 显示出强大的生化疗效和良好的安全性.
- 贝扎菲布拉特是改善胆固醇和的已知非标签选择.
- 更新的诊断和风险分层策略对于最佳的患者管理至关重要.
结论:
- 新型PPAR激动剂代表了二线治疗PBC的重大进展.
- 个性化治疗理念和及时调整是改善患者结果的关键.
- 有效的控制仍然是PBC的关键治疗目标.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
127
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
127
Chronic Bowel Disorders: Introduction
536
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
536
Acute Pancreatitis II: Clinical Manifestations and Management
173
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
173
Diseases of the Liver and Gallbladder
957
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
957
Chronic Pancreatitis I: Introduction
147
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
147
Inflammatory Bowel Disease IV: Pharmacological Management
177
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
177


